Company Filing History:
2 out of 2 
2 out of 7 Years Active: 2020-2022
Title: Innovator Spotlight: Qingqing Zhang
Introduction
Qingqing Zhang, an accomplished inventor based in Jiangsu, China, has made significant contributions to the field of biopharmaceuticals. With a portfolio of four patents, Zhang's innovations are shaping the way we approach drug development and treatment options for various diseases.
Latest Patents
Zhang's most notable patents include a revolutionary bispecific antibody or antibody mixture with common light chains. This application not only outlines the preparation method but also provides a nucleic acid molecule encoding the antibody or mixture, along with a recombinant vector and a recombinant cell. It introduces a detection and quantitation method for the antibody or the mixture, showing great promise in therapeutic contexts.
Another notable invention is the 2,4,6-trisubstituted s-triazine compound. This compound is represented by a specific general formula and includes pharmaceutically acceptable salts, prodrugs, or solvates. Zhang's patent describes a preparation method and the use of these compounds for creating drugs aimed at preventing or treating diseases linked to protein kinase and vimentin dysregulation. Notably, these innovations target critical issues like cancer growth, metastasis, tissue fibrosis, and atherosclerosis.
Career Highlights
Throughout his career, Qingqing Zhang has played pivotal roles in organizations that focus on innovative biopharmaceutical solutions. Notable companies he has worked with include Aluda Pharmaceuticals, Inc. and Jiangsu Alphamab Biopharmaceuticals Co., Ltd. His expertise in drug development has led to advancements that benefit patients and the broader medical community.
Collaborations
Zhang has had the opportunity to collaborate with talented individuals in his field, including Qizheng Yao and Jianping Wu. These collaborations foster an environment of creativity and significant progress in the ongoing quest for effective treatments across various medical conditions.
Conclusion
Qingqing Zhang stands out as a prominent figure in biopharmaceutical innovation, with his groundbreaking patents contributing to the development of essential treatments. His work not only showcases his expertise but also highlights the collaborative spirit prevalent in the research community. As the landscape of biopharmaceuticals continues to evolve, Zhang's contributions will likely play a crucial role in shaping future therapeutic strategies.